Anti-drug crackdown: 6 more youths arrested in Mangaluru; 6 in Puttur

Mangaluru, May 10: A delegation of Muslm community leaders called on Dakshina Kannada deputy commissioner Sindhu B Roopesh and discussed her about quarantine facilities for Indians returning from Gulf amidst covid-19 lockdown.

First evacuation flight from Dubai to Mangaluru will operate on May 12. Demand is mounting on the Centre to operate more flights from Gulf countries including UAE and Saudi Arabia.

International passengers will not be direct sent home after they land at any Indian airport. They will be divided into two categories. After screening at the airports, symptomatic will be sent directly to the covid-19 hospitals and asymptomatic and healthy will be sent for mandatory quarantine in designated hotel rooms and guest houses.

District administration has clarified that those who are under quarantine in hotels and guest houses will not be allowed to have outside food. Nor they will be allowed to contact anyone.

The delegation brought to the notice of DC that there will be many fasting Muslims among Gulf returnees and they need Suhoor and Iftar facility during Ramadan. The DC positively responded and assured that such facility will be arranged in the hotel rooms.

The delegation also asked about the claim of the officials of ministry of external affairs that delay in arranging quarantine facility in Karnataka delayed the evacuation flights from Gulf countries to the state. The DC said that the district administration has already made necessary arrangements for those who are coming to Dakshina Kannada.

Led by Mangaluru MLA U T Khader, the delegation comprised of JD(S) MLC B M Farookh, S M Rasheed Haji, Shafi Saadi, Mumtaz Ali, Kanchur Monu, B A Mohiuddin Bava, Ibrahim Kodichal, Rasheed Haji of Ullal Dargah and others.

Mangaluru, Apr 22: Iftar parties, Taraweeh and weekly Friday prayers in mosques have been banned in the district during Ramadan amid Coronavirus theat, Dakshina Kannada Deputy Commissioner Sindhu B Rupesh said here on Wednesday.

In a release issued here, she said, “As per the guidelines issued by the State government and Wakf Board, arranging Iftar gathering, and offering Taraveeh Namaz and Friday Namaz at mosques or dargas during the month of Ramadan has been prohibited as a precaution measure to prevent the spread of coronavirus. Therefore, offer prayers at homes instead of going to mosques," the DC said.

“No one can perform Namaz in the mosques except the muezzin and the Pesh imam and the staff of the mosque. Also, gathering neighbors and offering collective prayers at anybody's home is also not allowed. Masjid administration committees must follow the directives of the government, Wakf Board and the District Administration”, the DC urged.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.